Keyphrases
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
7%
Age of Onset
11%
Alpha-synuclein (α-syn)
11%
Alzheimer's Disease
7%
Basal Ganglia
7%
Blepharospasm
8%
Blood Flow
7%
Cerebral Blood Flow
5%
Cervical Dystonia
18%
D2 Receptor
11%
D2-like
6%
Deep Brain Stimulation
16%
Dementia
7%
Dopamine
11%
Dopamine D2 Receptor (DRD2)
8%
Dystonia
32%
Flow Response
7%
Focal Dystonia
6%
Functional Connectivity
7%
Gait
7%
Huntington's Disease
32%
Idiopathic Parkinson's Disease
11%
Levodopa
17%
Macaque
6%
Movement Disorders
8%
Neurodegenerative Diseases
6%
Neuroimaging
5%
Parkinson Patients
9%
Parkinson's Disease
100%
Parkinsonism
14%
Pathophysiology
8%
Patients with Parkinson's Disease
6%
Positron Emission Tomography
35%
Premanifest Huntington's Disease
7%
Putamen
6%
Radioligand
18%
Radiosynthesis
8%
Radiotracer
16%
Receptor Binding
11%
Regional Cerebral Blood Flow (rCBF)
10%
Rodents
7%
Sphingosine-1-phosphate Receptor (S1PR)
9%
Striatal
17%
Striatal Dopamine
5%
Striatum
10%
Subthalamic nucleus
8%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
17%
Tremor
6%
Unified Parkinson's Disease Rating Scale (UPDRS)
7%
Vesicular Acetylcholine Transporter (VAChT)
13%
Neuroscience
Alzheimer's Disease
8%
Amyloid Protein
5%
Basal Ganglia
6%
Behavior (Neuroscience)
6%
Blepharospasm
5%
Cerebellum
5%
Deep Brain Stimulation
21%
Dopamine Receptor D2
7%
Dopamine Receptor D3
5%
Dopaminergic
11%
Dystonia
33%
Familial Parkinson's Disease
6%
Fluorine-18
29%
Functional Connectivity
8%
Haplotype
5%
Huntington's Disease
18%
In Vitro
12%
In Vivo
21%
L-DOPA
17%
Magnetic Resonance Imaging
7%
Metabolic Pathway
5%
Parkinson's Disease
97%
Parkinsonism
16%
Positron Emission Tomography
40%
Positron Emission Tomography
20%
Putamen
10%
Quality of Life
7%
Radioligand
16%
Receptor
16%
Receptor Binding
10%
Resting-State Functional Connectivity
5%
Spasmodic torticollis
13%
Sphingosine-1-Phosphate Receptor
7%
Stereotypic Movement Disorder
9%
Striatum
8%
Subthalamic Nucleus
17%
Synuclein
8%
Tetrahydropyridine
7%
Tremor
13%
Vesicular Acetylcholine Transporter
9%